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PLATELET-ACTIVATING factor receptor (PAF-R) transcripts
were  analysed  by  reverse  transcriptase-polymerase
chain reaction in five human cancer cell lines derived
from the breast (BT20,  SKBR3 and T47D  cells),  the
pancreas (Miapaca cells) and the bladder (5637 cells)
in order to confirm the existence of a splice variant of
the PAF-R transcript 2. After cloning and sequencing,
we confirmed its  existence in all  cell  lines. It  con-
sisted of the PAF-R transcript 2 lengthening with 82
nucleotides from the 39 end of exon 1 of the PAF-R
gene. The role of this elongated form of the tissue-
type PAF-R transcript in cell physiology remains to be
elucidated.
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Platelet-activating  factor  is  an  inflammatory  lipid
molecule  that acts through platelet-activating factor
receptors  (PAF-R)  present  on  the  membrane  of
responsive cells.1 The human PAF-R gene is encoded
by a unique gene (exon 3) composed of two 59-non-
coding exons (exons 1 and 2). Thus, the PAF-R gene
produces  two  different  species  of  mRNA  (i.e.  tran-
scripts  1  and  2)  that generate a unique  membrane
PAF-R (Fig. 1A). It is well known that hematopoietic
cells only express PAF-R transcript 1 (exons 1 + 3)
while transcripts 1 and 2 (exons 2 + 3) are found in
various organs such as the lung, spleen and heart.1–4
The presence of an elongated splice PAF-R variant in
the 59-untranslated region of the PAF-R transcript 2
has  been  documented  in  human  colonic  epithelial
tumour cell lines.5 In these cells, the PAF-R transcript
2 was lengthened with 82 nucleotides from the 39 end
of exon 1, generating a third PAF-R transcript. To our
knowledge, no study has reported the existence of
this elongated PAF-R transcript 2 in other cell types.
The  present study was thus designed to ensure  its
presence in human cancer cell lines derived from the
breast, pancreas and bladder.
SKBR3, BT20 and T47D cells (three human breast
cancer cell lines), Miapaca cells (a human pancreatic
cancer  cell  line)  and  5637  cells  (a  human  bladder
cancer cell line) were routinely grown in RPMI 1640
with 10% fetal calf serum (Life Technologies, Cergy
Pontoise, France), penicillin (100U/ml) and strepto-
mycin (100mg/ml) at 37°C in 5% CO2 in air. Total RNA
was extracted from SKBR3, BT20, T47D, Miapaca and
5637  cells  with Tripure  (Roche  GmbH,  Mannheim,
Germany). Reverse transcription was carried out for
1h with Superscript (Life Technologies, Cergy Ponto-
ize,  France),  starting  with  1mg  of  total  RNA. The
complementary DNA (cDNA) was then amplified by
polymerase  chain  reaction  (PCR).  Reactions  were
carried out in 30ml of a mix made up of 8 mM dNTP,
100nM of each primer, 1 ´ Taq buffer and 0.2U of Taq
Polymerase (Amersham Biosciences, Orsay,  France).
The  PAF-R  transcript  1  sense  primers  were
59-ACTTGGTAGTGATACGCTCTGTTTCTT-39 (P1) and
59-GACAGCATAGAGGCTGAG-GC-39 (P19),  the  tran-
script  2  sense  primer  was  59-CCTGAGCTCCCCGA-
GAAGTCA-39 (P2),  and  the  antisense  primer  was
59-TAGCCATTAGCAATGACCCC-39 (P3) (Fig. 1A). The
constitutive expression of b-actin in all cell samples
represented a  positive control of  reverse transcrip-
tion  (data  not  shown). As  a  negative  control,  the
PCR  reaction  was  performed  with  all  reagents
except  the  cDNA. PCR was  performed on  a  Robo-
cycler  Gradient  96  (Stratagene,  La  Jolla,  CA,  USA).
DNA  was  denatured  for  180sec  at  94°C,  then
submitted to 35 cycles consisting of 94°C for 30sec,
60°C for 60sec (with the P19 sense primer) or 64°C
for 60sec (with P1 and P2 sense primers) and 72°C
for  90sec. A  final  elongation  step  was  realised  at
72°C for 10min. Products were then analysed on a
1.2%  agarose  gel  stained  with  ethidium  bromide.
PCR products were cloned in Topo vector (Topo™
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and sequenced by the dideoxynucleotide method on
an  ABI  Prism  310  DNA  genetic  analyser  (Applied
Biosystems, Foster City, CA, USA).
Using  P1  and  P3  primers,  a  269  base  pair  (bp)
fragment  related  to  the  PAF-R  transcript  1  was
amplified with BT20, T47D, Miapaca and 5637 cells,
but not with SKBR3 cells (Fig. 1B). After cloning and
sequencing,  we  found  (data  not  shown)  that  the
269bp  sequence  was  identical  to  the  previously
reported  PAF-R  transcript  1.2 Using  P2  and  P3
primers, 269  and  351bp  fragments  were  amplified
from the five human cancer cell lines (Fig. 1C). After
cloning  and  sequencing,  we  found  (data  not
shown) that the 269bp sequence was identical to the
PAF-R transcript 2.2 As previously reported by Kotele-
vets  et  al.,5 our  351bp  fragment  was  the  269bp
fragment  lengthened  at  the  39 end  of  exon  2  by
the following 82  nucleotides present at the 39 end
of  exon  1:  ACAGCATAGAGGCTGAGGCTGGGGCC
AGGACCCAGACAGAGACACACGGTCACTGCAGCTG-
AAGCCGCTGCCCCTGCTACAG.  Using  P19 and  P3
primers,  a  225bp  fragment  related  to  the  PAF-R
transcript 1  was amplified,  showing that the splice
variant  of  the  PAF-R  transcript  2  may  serve  as  a
template for PCR amplification (Fig. 1D).
PAF-R  transcript  1,  which  is  found  in  numerous
hematopoietic cells,1,3,4 is  detected in  several  non-
hematopoietic cell lines such as BT20, T47D, Miapaca
and  5637  cells,  but  not  in  SKBR3  cells.  PAF-R
transcript 2 (not detected in hematopoietic cells) is
expressed by all these human cancer cell lines derived
from the breast, pancreas and bladder. These five cell
lines  also  express  the  splice  variant  of  the  PAF-R
transcript  2  showing,  for  the  first  time,  that  its
expression  is  not  restricted  to  colonic  epithelial
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FIG. 1. Expression of PAF-R transcripts in human cancer cell lines derived from the breast (SKBR3, BT20 and T47D cells), the
pancreas (Miapaca cells) and the bladder (5637 cells). (A) Schematic representation of the PCR analysis of PAF-R expression.
(B) Expression of PAF-R transcript 1 (P1 and P3). (C) Expression of PAF-R transcript 2 and of its elongated form (P2 and P3). (D)
Expression of PAF-R transcript 1 and/or of the elongated splice variant of PAF-R transcript 2 (P19 and P3). Lane 1, DNA size
ladder; lanes 2–6, BT20, T47D, SKBR3, Miapaca and 5637 cells, respectively; lane 7, PCR blank.tumor cell lines.5 So far, the physiological function of
this  elongated  form  of  the  PAF-R  transcript  2  is
unknown. As suggested by Kotelevets et al.,5 it might
provide additional flexibility in the control of PAF-R
gene expression. It might have a potential role in the
formation of secondary structures for a better transla-
tion  initiation  and/or  for  higher  interactions  with
nuclear factors. Clearly further studies are required to
clarify  the  role  of  the  splice  variant  of  the  PAF-R
transcript 2 in organ physiology.
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